# Funding Related Articles

HTX News Center provides the latest articles and in-depth analysis on "Funding", covering market trends, project updates, tech developments, and regulatory policies in the crypto industry.

Exclusive | ByteDance's AI Drug Discovery Unit Initiates Spinoff and Funding, AI4S Enters Industrialization Phase

Exclusive | ByteDance’s AI Drug Discovery Unit Initiates Spin-off for Financing, Signaling Industrialization Phase for AI4S. ByteDance’s AI drug discovery business line has begun the process of spinning off as an independent entity to raise outside funding, marking a key step toward industrializing its AI for Science (AI4S) efforts. Post-spin-off, ByteDance will remain the controlling shareholder. The new company will inherit the core team, algorithms, technology platform, and existing pipeline assets. It will also continue to receive computing power support from ByteDance's Volcano Engine. The AI drug discovery team, established in 2021 and led by Liu Kai with a core team of about 50 AI and pharmaceutical experts, has been responsible for foundational model research and industrialization. It has consolidated ByteDance's protein structure prediction model team and launched several key technologies. These include the molecular structure prediction models Protenix and Seedfold, the protein design tool PXDesign, and the AI drug discovery platform "Anew Labs." Anew Labs has produced research covering protein-ligand dynamics, molecular generation, and free energy calculation, and has developed early-stage drug pipelines like IL-17 and IL4R inhibitors. Notably, its IL-17 small molecule program, presented in April 2026, demonstrated the first small-molecule blockade of three IL-17 dimers, a significant step in autoimmune disease research. This progress demonstrates ByteDance’s AI capabilities have advanced from model development to validating specific drug targets and molecules. The company believes the opportunity to transition from research to industry is now ripe. The spin-off aims to establish an organizational structure better suited to the business's unique needs—long R&D cycles and complex validation processes involving wet labs and clinical trials—to attract top talent and drive deeper integration of AI with the pharmaceutical industry. The move responds to the pharmaceutical industry's pressing need to improve efficiency amid high R&D costs, long timelines, and high failure rates. The field of AI4S is rapidly advancing, as seen with tools like AlphaFold evolving from protein prediction to modeling complex biological interactions and the emergence of multimodal molecular generation models for drug design. ByteDance has been building its AI4S capabilities for years, exploring areas like computational biology, molecular simulation, and materials science. This spin-off represents its first major attempt to industrialize AI4S. An insider stated the company attaches great importance to this move, hoping that an independent entity with greater decision-making flexibility can pioneer a viable industrial path for AI4S in China.

marsbit06/10 06:26

Exclusive | ByteDance's AI Drug Discovery Unit Initiates Spinoff and Funding, AI4S Enters Industrialization Phase

marsbit06/10 06:26

Valuation Surpasses 200 Billion, Kimi Reportedly Raises 13.6 Billion More, Speeds Up Hong Kong IPO

Beijing-based AI unicoth MoonDark (Kimi) is reportedly in talks for a new funding round aiming to raise up to $20 billion (approximately RMB 136 billion), targeting a post-money valuation of $300 billion (approximately RMB 2.035 trillion). If successful, this would mark its third round in six months and a six-fold increase from its $43 billion valuation in December last year. Last month, the company completed a $20 billion funding round led by Meituan Longzhu, reaching a valuation exceeding $200 billion. According to reports, MoonDark has raised over RMB 376 billion across six rounds, making it the most funded large language model startup in China. Founded in 2023 by CEO Yang Zhilin, the company's core product is the Kimi AI Assistant. In April, it launched and open-sourced its flagship model, Kimi K2.6, which has demonstrated performance comparable to top models like GPT-5.4 in certain benchmarks. Recently, it began beta testing for Kimi Work, a local AI agent for knowledge workers. Commercially, the company's Annual Recurring Revenue (ARR) reportedly surpassed $2 billion in April. Regarding its IPO plans, Bloomberg reported in March that MoonDark is preparing for a listing in Hong Kong, though the process remains in early stages. The funding and IPO pace for leading Chinese AI firms has accelerated notably in 2026, mirroring global trends where companies like OpenAI and Anthropic are also setting new fundraising and valuation records. Securing substantial capital is becoming a critical factor in the competitive landscape alongside model capabilities.

marsbit06/08 07:45

Valuation Surpasses 200 Billion, Kimi Reportedly Raises 13.6 Billion More, Speeds Up Hong Kong IPO

marsbit06/08 07:45

Token Inefficient, Economy Tokenless

The article "Tokens Aren't Economical, Economics Aren't Tokenized" analyzes a pivotal shift in the AI industry from a technology-driven narrative to one dominated by capital efficiency. It highlights two concurrent trends: a severe capital shortage due to the exorbitant and recurring costs of compute (e.g., OpenAI's high burn rate) and a wave of corporate spin-offs where major tech companies are separating their AI units (like Kuaishou's Kling and Baidu's Kunlunxin). The core argument is that AI's "anti-internet" business model, where user growth increases costs rather than profits, has created a disconnect between high valuations and actual cash flow. Spin-offs address this by allowing AI assets to be valued independently. Within a parent company, they are seen as cost centers, but as standalone entities, they are priced based on their growth potential and scarcity in the primary market, leading to massive valuation premiums (e.g., Kling's estimated value tripling post-spin-off). The industry is at an inflection point, moving from "model worship" to "value realization." The competition is evolving from a pure compute (GPU) race to a broader focus on systemic efficiency and full-stack engineering (involving CPUs and orchestration) to achieve viable commercialization. The year 2026 is framed as a critical moment where the industry must definitively answer how to economically translate AI capability into tangible business value, reshaping the sector's future power structure.

marsbit06/05 11:13

Token Inefficient, Economy Tokenless

marsbit06/05 11:13

Morning Post | Bitmine Plans to Raise $300 Million Through Preferred Stock Issuance; Polymarket Accuses Kalshi of Commercial Espionage

ChainCatcher's Daily Crypto Brief: Key developments from the past 24 hours include significant funding moves, regulatory actions, and market predictions. Bitmine announced a $300 million preferred stock fundraising. Polymarket accused rival prediction platform Kalshi of corporate espionage, citing numerous suspicious coincidences in product launches, a claim Kalshi strongly denied. The U.S. Department of Justice, in a joint "Disruption Week" anti-fraud operation with companies like Coinbase and Meta, froze over $3.8 million in cryptocurrency linked to scams. In infrastructure news, Macau completed its integration with the multi-central bank digital currency bridge, mBridge, aiming to build efficient cross-border payment channels. Cosmos Labs acquired the block explorer Mintscan. Market-wise, Geoffrey Kendrick, Standard Chartered's Head of Digital Assets Research, stated Bitcoin is nearing a bottom around $63,000, maintaining a year-end target of $100,000. He noted stability in U.S. spot Bitcoin ETF holdings. Ahead of SpaceX's anticipated IPO, internal insiders at Rocket Lab (RKLB) sold over $18.41 million in stock. In tokenization, Goldman Sachs partnered with Apex and Archax to launch a tokenized real estate fund. The meme token tracker GMGN reported the top trending tokens: on Ethereum, HEX, SHIB, LINK, PEPE, mUSD; on Solana, TROLL, swarms, WORLDCUP, neet, Buttcoin; and on Base, PEPE, toby, ODDS, ELSA, SKI.

链捕手06/05 01:32

Morning Post | Bitmine Plans to Raise $300 Million Through Preferred Stock Issuance; Polymarket Accuses Kalshi of Commercial Espionage

链捕手06/05 01:32

活动图片